SCHEMBL25677449

SCHEMBL25677449

CC(C)(C)c1cc(C(C)(C)C)c2c(c1)c1ccccc1n2-c1nc(-n2c3ccccc3c3cc(C(C)(C)C)cc(C(C)(C)C)c32)nc(-n2c3ccccc3c3cc(C(C)(C)C)cc(C(C)(C)C)c32)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.32
▸ PGR P06401 1/20 0.31
▸ RORA P35398 1/20 0.31
▸ RORC P51449 1/20 0.31
▸ RORB Q92753 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GPR3 P46089 1/20 0.31
▸ POLB P06746 1/20 0.30
▸ PPARG P37231 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25677425 0.99 KIF11 (0.32) KIF11KDM4EATML3MBTL1HSP90AA1
SCHEMBL25677422 0.99 KIF11 (0.32) KIF11KDM4EATML3MBTL1HSP90AA1
SCHEMBL25685877 0.94 PIK3CD (0.31) —
SCHEMBL25677935 0.92 KDM4E (0.30) KDM4EPOLB
SCHEMBL25677406 0.92 ABCG2 (0.40) KDM4EATML3MBTL1HSP90AA1TSHR
SCHEMBL25677427 0.91 KDM4E (0.38) KDM4EHSP90AA1MAPT
SCHEMBL25685887 0.90 PIK3CA (0.31) PGRRORARORCRORBCYP1A2
SCHEMBL25677444 0.90 KDM4E (0.38) KDM4EHSP90AA1MAPT
SCHEMBL25677403 0.90 ABCG2 (0.40) KDM4EATML3MBTL1HSP90AA1TSHR
SCHEMBL25677435 0.89 ABCG2 (0.38) KDM4ELMNAALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-01 — — US disclosed
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, NQO1, CYP2E1 KIF11 3925/4885KDM4E 3248/4885ATM 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback